Clinical Trial Update: 12- Week Open Label Treatment of Refractory Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reporting results from a 12-week open-label treatment for refractory bipolar depression; the study is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-05-21